As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Ahmed Dehal is a board-certified general surgeon with a second board certification in complex surgical oncology at the Kaiser Permanente Panorama City Medical Center. He serves as area research chair for Panorama City on the Southern California Permanente Medical Group Regional Research Committee. He is an associate professor in Clinical Science at the Kaiser Permanente Bernard J. Tyson School of Medicine. Dr. Dehal has published more than 40 articles in peer-reviewed journals as well as multiple ...
Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)
Dr. Michael Kanter is an associate investigator with the Department of Research & Evaluation and the chair of Clinical Science and a professor for the Kaiser Permanente Bernard J. Tyson School of Medicine. He has been a quality care leader for Kaiser Permanente at both the regional and national levels for many years and was responsible for ...
Non-muscle invasive bladder cancer patients whose treatment included the immunotherapy Bacillus Calmette-Guerin (BCG) after surgery were less likely to have their cancer recur if their diet included raw cruciferous vegetables like broccoli, a new Kaiser Permanente study found. The research, published in the Journal of Urology, analyzed data from patients enrolled in the Bladder Cancer ...
Being active can lower your risk of getting seriously ill with COVID, regardless of your race or the chronic conditions you may have, according to research published last year in the American Journal of Preventive Medicine. The Kaiser Permanente Southern California findings were important, impactful, and influential. As a result, the journal editors chose the ...
A study of 316,443 patients shows that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend, and of those who repeated home tests, over half did not have a colonoscopy within one year. Colorectal cancer is the second most common cancer-related cause of death in the United States, but ...
A nurse and health services researcher, Huong Q. Nguyen, PhD, RN, focuses her research on the care of older adults with chronic and serious illnesses. She is the co-lead of the Care Improvement Research Team and interim director of the Division of Health Services Research & Implementation for the Department of Research & Evaluation. She ...
Kaiser Permanente Southern California’s legacy of research aimed at improving health and health care began in the early 1950s. In the beginning, it was physicians who used what they were seeing in the clinic to power research for the broader world. Now celebrating its 60th anniversary, the program conducts research used as evidence for national and international policymaking as well as many improvements to patient care. In this IMPACT, we share our 2023 Annual Report and the history of our program.
Investigators with the Division of Epidemiologic Research apply rigorous research methods to address important health questions that have the potential to change clinical practice and health care delivery. The division’s research portfolio spans the care continuum, from etiology and prevention to survivorship and quality of life.
Division investigators have expertise in traditional epidemiologic studies, post-marketing safety and effectiveness studies, and outcomes research. Current research areas include cancer, cardiovascular disease, COVID-19, diabetes, infectious disease, molecular epidemiology, orthopedics and bone health, perinatal health, pharmacoepidemiology, and vaccines.